Comprehensive quantum chemical analysis, vibrational spectroscopy, molecular docking, ADMET, and in vitro validation studies of hydroxychloroquine-MRGPRX2 complex in IDH-wildtype glioblastoma. [PDF]
PLoS OneDemirag AD +4 more
europepmc +1 more source
Efficacy and safety of hypofractionated radiotherapy combined with temozolomide in patients with newly diagnosed glioblastoma with poor prognosis: a single-center retrospective analysis. [PDF]
Front OncolFu F +8 more
europepmc +1 more source
Glioblastoma, <i>IDH-</i>wildtype, with a novel <i>MEF2D-NTRK1</i> gene fusion: a case report. [PDF]
Front OncolDewey A +5 more
europepmc +1 more source
Retraction Note: Anlotinib combined with temozolomide suppresses glioblastoma growth via mediation of JAK2/STAT3 signaling pathway. [PDF]
Cancer Chemother PharmacolXu P, Wang H, Pan H, Chen J, Deng C.
europepmc +1 more source
Role of CTLA-4 blockade and dacarbazine therapy following anti-PD-1 resistance in melanoma. [PDF]
Discov OncolUrbonas V, Dulskas A.
europepmc +1 more source
Real-World Effectiveness of Capecitabine and Temozolomide Across Endocrine and Neuroendocrine Neoplasm Subtypes (ENENs): A Population-Based Cohort Study from Alberta, Canada (2011-2021). [PDF]
Curr OncolAleksi A +7 more
europepmc +1 more source
Targeted and systemic therapies for recurrent adult ependymomas: real-world outcomes from a single institution and concise literature review. [PDF]
Front OncolMaccari M +14 more
europepmc +1 more source
Bitter Taste Signalling via TAS2R43 Enhances Temozolomide Efficacy in Glioblastoma Cells. [PDF]
Int J Mol SciCosta AR +6 more
europepmc +1 more source